Azithromycin in Addition to Standard of Care vs Standard of Care Alone in Patients Admitted With Severe COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Azithromycin in Addition to Standard of Care Versus Standard of Care Alone in the Treatment of Patients Admitted to the Hospital With Severe COVID-19 in Brazil (COALITION II): A Randomised Clinical Trial
Lancet 2020 Sep 04;[EPub Ahead of Print], RHM Furtado, O Berwanger, HA Fonseca, TD Corrêa, LR Ferraz, MG Lapa, FG Zampieri, VC Veiga, LCP Azevedo, RG Rosa, RD Lopes, A Avezum, ALO Manoel, FMT Piza, PA Martins, TC Lisboa, AJ Pereira, GB Olivato, VCS Dantas, EP Milan, OCE Gebara, RB Amazonas, MB Oliveira, RVP Soares, DDF Moia, LPA Piano, K Castilho, RGRAP Momesso, GPP Schettino, LV Rizzo, AS Neto, FR Machado, AB CavalcantiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.